SOTIO seeks partner to test cancer drugs

Published: 10.05.2021 Related countries:  Singapore Singapore

SOTIO seeks partner to test cancer drugs

SOTIO is negotiating a partnership with pharmaceutical companies in the field of cancer drug testing. This was confirmed to ČIANEWS by SOTIO spokesman Richard Kapsa, stating that the company has been cooperating with companies developing innovative anti-cancer products for many years. These include for instance the Swiss NBETherapeutics. In 2020, SOTIO began construction of a specialized centre for T cell therapies, including research laboratories, in Camebridge, USA. At the same time, it is preparing for possible admission to a stock exchange in the USA. (Source: ČIA News, www.cianews.cz/en)